Heidy King-Jones
CIK 1794898 · See Remarks · last filed 2026-01-13
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
13
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRE | See Remarks | — | $80.79 | — | $0 | 3 | 2026-01-13 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | See Remarks | — | $12.01 | — | $0 | 1 | 2023-09-05 |
| Provention Bio, Inc. (PRVB) Delisted | Chief Legal Officer | — | $24.98 | — | $0 | 8 | 2023-04-27 |
| Axcella Health Inc. (AXLA) Delisted | General Counsel, SVP Legal | — | $0.40 | — | $0 | 1 | 2019-12-20 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-14 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-03 | Provention Bio, Inc. (PRVB) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-12-20 | Axcella Health Inc. (AXLA) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.